Register

Site

National Cancer Institute of Canada Clinical Trials Group

Content

The Summary of In Progress Clinical Trials includes details of about 60 current trials, defined as active, planned and recently closed trials, undertaken by the NCIC Clinical Trials Group. The listing is intended for use by doctors and healthcare professionals, while the site as a whole is intended for Group members at participating centres. There is advice for patients on where to obtain further information and advice.
The listings are sub-divided into:
Investigational New Drug (IND) Program Trials (total of 25 trials)
Phase III Site Committee Trials (total of 42)
These are further sub-divided into cancer sites, as follows:
Cancer of the:
Brain
Breast
Gastro-intestinal
Genito-urinary
Gynecologic Head and neck
Hematologic
Lung
Melanoma
Sarcoma
Symptom control

The NCIC CTG is a co-operative oncology group based at Queens University, Kingston, Ontario. It is a national programme of the National Cancer Institute of Canada.

Other information available

There is an area for Participating Member Centres only, which requires authentication information. This section (not visited) includes more information on current trials, including downloadable protocols, and details of committee memberships, and newsletters and special supplements.
The rest of the (unrestricted) site includes news, trial results and publications, details of meetings/conferences, and links to related sites.

Access

Access to the unrestricted areas of the site is free, no password or pre-registration required. However, the Participating Member Centres area requires registration.

Comments

There is a keyword search facility for the whole site, which was last updated on February 9, 2000. The Clinical Trials pages state ‘as of January 01, 2000’.

Register

Site

National Cancer Institute of Canada Clinical Trials Group

Content

The Summary of In Progress Clinical Trials includes details of about 60 current trials, defined as active, planned and recently closed trials, undertaken by the NCIC Clinical Trials Group. The listing is intended for use by doctors and healthcare professionals, while the site as a whole is intended for Group members at participating centres. There is advice for patients on where to obtain further information and advice.The listings are sub-divided into:Investigational New Drug (IND) Program Trials (total of 25 trials)Phase III Site Committee Trials (total of 42)These are further sub-divided into cancer sites, as follows: Cancer of the:BrainBreastGastro-intestinalGenito-urinaryGynecologic Head and neckHematologicLungMelanomaSarcomaSymptom control The NCIC CTG is a co-operative oncology group based at Queens University, Kingston, Ontario. It is a national programme of the National Cancer Institute of Canada.

Other information available

There is an area for Participating Member Centres only, which requires authentication information. This section (not visited) includes more information on current trials, including downloadable protocols, and details of committee memberships, and newsletters and special supplements.The rest of the (unrestricted) site includes news, trial results and publications, details of meetings/conferences, and links to related sites.

Access

Access to the unrestricted areas of the site is free, no password or pre-registration required. However, the Participating Member Centres area requires registration.

Comments

There is a keyword search facility for the whole site, which was last updated on February 9, 2000. The Clinical Trials pages state ‘as of January 01, 2000’.